XML 19 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net income $ 79,850 $ 488,227
Adjustment for (income) loss from discontinued operations 371 10,782
Income (loss) from continuing operations 80,221 499,009
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 284,620 288,942
Amortization of debt discount and debt issuance costs 752 531
(Recovery of) bad debt (75)  
Provision for bad debt   429
Stock-based compensation 16,589 15,546
Loss on investment securities 36,957  
Gain on sale of assets (17,090) (10,820)
Deferred income tax (benefit) expense 8,827 (506,373)
Other (3,209) 5,701
Change in assets and liabilities increasing (decreasing) cash:    
Accounts receivable 13,642 (61,791)
Inventories of materials and supplies (3,268) (5,973)
Prepaid expenses and other 3,960 6,992
Other noncurrent assets (4,602) (4,993)
Accounts payable (2,639) (13,119)
Accrued liabilities (456) 12,918
Deferred income tax liability 160 (5,980)
Other noncurrent liabilities (5,326) (13,272)
Net cash provided by operating activities from continuing operations 409,063 207,747
Net cash used in operating activities from discontinued operations (45) (96)
Net cash provided by operating activities 409,018 207,651
Cash flows from investing activities:    
Capital expenditures (329,980) (191,202)
Purchase of short-term investments (42,406) (36,784)
Payment for acquisition of business, net of cash acquired (2,781) (47,886)
Proceeds from sale of short-term investments 58,015 32,020
Proceeds from asset sales 24,559 17,826
Net cash used in investing activities (292,593) (226,026)
Cash flows from financing activities:    
Dividends paid (156,580) (153,433)
Debt issuance costs paid (3,912)  
Proceeds from stock option exercises 2,257 1,645
Payments for employee taxes on net settlement of equity awards (6,268) (5,791)
Payment of contingent consideration from acquisition of business   (4,500)
Net cash used in financing activities (164,503) (162,079)
Net decrease in cash and cash equivalents and restricted cash (48,078) (180,454)
Cash and cash equivalents and restricted cash, beginning of period 326,185 560,509
Cash and cash equivalents and restricted cash, end of period 278,107 380,055
Cash paid during the period:    
Interest paid 13,234 11,796
Income tax paid, net 9,127 3,278
Changes in accounts payable and accrued liabilities related to purchases of property, plant and equipment $ 12,734 $ 237